Update Your Profile Member Spotlights Refer a Member: IASP Champions Join a Special Interest Group (SIG) Find a Chapter Join Now
PAIN PAIN Reports Pain Research Forum Papers of the Week Webinars and Podcasts Events
Online Learning - PERC Webinars & Podcasts Curricula Graduate Opportunities Events
RELIEF News Resources for Living with Pain Global Alliance of Partners in Pain Advocacy (GAPPA) Events
Support IASP Sponsor an Event Become a Partner
< BACK TO ARCHIVE
POW ARCHIVE WEEK: Papers: 8 May 2021 - 14 May 2021
STUDY TYPE:Human Studies, Pharmacology/Drug Development
PAIN TYPE:Migraine/Headache
DATE PUBLISHED: 2021 May 13
JOURNAL:Cephalalgia
PUBMED: http://www.ncbi.nlm.nih.gov/pubmed/33982623?dopt=Abstract
Ictal cutaneous allodynia, common in chronic migraine, is associated with reduced responses to acute treatment with triptans. Allodynia's impact on the efficacy of newer preventive treatments such as erenumab is unknown.
